ascendis pharma glp-1 receptor agonist Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug What is GLP-1 and Its

Glucagon-like peptide-1 receptor agonists, namely GLP-1 receptor agonists, are a class of drugs for the treatment of type 2 diabetes.

The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust your workout routine when taking a GLP-1.

GLP-1 is a peptide hormone secreted by L cells in the ileum and colon

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

The term natural is often misunderstood

Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy